Zobrazeno 1 - 10
of 36
pro vyhledávání: '"James C.-Y. Chou"'
Autor:
Adel A. Wassef, Paul E. Keck, Alan C. Swann, Linda J. Rhodes, Patricia Wozniak, Susan L. McElroy, Harrison G. Pope, Frederick Petty, Joseph R. Calabrese, Charles L. Bowden, James C.-Y. Chou, Robert M. A. Hirschfeld, Laszlo Gyulai
Background Long-term outcomes are often poor in patients with bipolar disorder despite treatment; more effective treatments are needed to reduce recurrences and morbidity. This study compared the efficacy of divalproex, lithium, and placebo as prophy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4861bbb26880fdf25dac47dd616637a1
https://doi.org/10.4324/9781315054308-25
https://doi.org/10.4324/9781315054308-25
Autor:
Norma Lopez, Deborah A. Perlick, James C.-Y. Chou, Carla Kalvin, David J. Miklowitz, Victoria Adzhiashvili, Andrew Aronson
Publikováno v:
Bipolar Disorders. 12:627-637
Bipolar disorder affects the family members of a patient and is affected by the family environments associated with caregiving. From 89% to 91% of family members report feelings of emotional distress (i.e., ‘subjective burden’) in relation to the
Autor:
James C.-Y. Chou, Lydia Fazzio
Publikováno v:
Journal of Psychiatric Practice. 12:283-299
The authors review available controlled trials of bipolar maintenance treatment and discuss the strengths and weaknesses of various study designs. Bipolar maintenance trials are organized according to the features of their designs, such as use of res
Autor:
Georges M. Gharabawi, James C.-Y. Chou, David Feifel, Glenn W. Currier, Cynthia A. Bossie, Ibrahim Turkoz, Ramy A. Mahmoud
Publikováno v:
The Journal of Clinical Psychiatry. 65:386-394
Background Standard treatment for acute psychotic agitation often involves intramuscular administration of the benzodiazepine lorazepam and the antipsychotic haloperidol. This study compared the efficacy and safety of oral treatment with the atypical
Autor:
Daniel E. Casey, David A. Sack, J. L. Peters, Herbert Y. Meltzer, Muriel Maurel-Raymondet, Carlos Morra, Sophie Frangou, Marie Agathe Zimmerman, Ravi Anand, Carlo Andrea Robotti, Vinod Kumar, Larry Alphs, Pedro L. Delgado, Eva Morik, K. Ranga Rama Krishnan, Vanda Benešová, Pierre Michel Llorca, Hannale Heila, Bernardo Carpiniello, Alberto Giannelli, Ann M. Mortimer, George T. Grossberg, Daniel L. Zimbroff, Shôn Lewis, Guy Chouinard, Saide Altinsan, Gyorgy Ostorharics-Horvath, Liliana Dell'Osso, Likiana Avigo, Jörg Pahl, Robert Kerwin, George M. Simpson, James C.-Y. Chou, Thomas Posever, Frederick Young, Robin Emsley, Elisabeth Bokowska, Oladapo Tomori, Santha Vaidain, Zdeòka Vyhnándová, Stephen Martin, Mary Ann Knesevich, Libor Chvila, Akos Kassaifarkas, Mojtaba Noursalehi, Vera Folnegovic, Richard Greenberg, Michael D. Lesem, Michael G. Plopper, Giovanni B. Cassano, Delbert Robinson, Nancy Temkin, Doris Gundersen, Ivo Paclt, Pedro Gargoloff, Frederic Khidichian, Laszlo Mod, Luis Bengochea, Naveed Iqbal, George Hsu, Steven G. Potkin, Thomas Fahy, Chuanchieh Hsu, Carl Eisdorfer, Rosario Pioli, Alan I. Green, Jack S. Krasuski, Miro Jakovljević, Siemion Altman, Mark Hyman Rapaport, Phillip Seibel, Jean Dalery, Richard C. Josiassen, Frédéric Rouillon, Veronica W. Larach, Isaac Sakinsofsky, Richard Balon, István Bitter, H. Edward Logue, Ira D. Glick
Publikováno v:
Biological Psychiatry. 54:444-452
Background Enhanced ability to reliably identify risk factors for suicidal behavior permits more focused decisions concerning treatment interventions and support services, with potential reduction in lives lost to suicide. Methods This study followed
Autor:
Patricia Wozniak, Susan L. McElroy, Charles B. Nemeroff, Frederick Petty, Charles L. Bowden, Robert M. A. Hirschfeld, Craig S. Risch, Dwight L. Evans, James C.-Y. Chou, Adel A. Wassef, Laszlo Gyulai, Alan C. Swann, Paul E. Keck, Joseph R. Calabrese
Publikováno v:
Neuropsychopharmacology. 28:1374-1382
Breakthrough depression is a common problem in the treatment of bipolar disorder. Only one, recently published, double-blind, placebo-controlled trial has examined the efficacy of divalproex in the prevention of depressive episodes in bipolar patient
Publikováno v:
Journal of Psychiatric Practice. 6:299-309
Antipsychotics are commonly used in bipolar disorder, both for acute mania and in maintenance treatment. The authors review available clinical research concerning the use of both conventional and atypical antipsychotics in bipolar disorder and presen
Autor:
Owen Charles, Rommel Bebe, Ivan Tuma, Thomas B. Cooper, Wen Ho Chang, Diane L. Stone, Pál Czobor, Hsien-Yuan Lane, James C.-Y. Chou
Publikováno v:
Journal of Affective Disorders. 59:55-59
Introduction: Pretreatment plasma homovanillic acid (HVA) levels have been reported to be a correlate of clinical response to typical antipsychotics for schizophrenic, bipolar manic, and mixed groups of psychotic patients. Biological markers of clini
Autor:
James C.-Y. Chou, Marc L. Copersino, Danielle Richarme, Robert Cancro, Andrea Bergman, Mark R. Serper
Publikováno v:
Psychiatry Research. 93:21-32
Impairments in verbal learning and memory functioning have been found to be cardinal features among individuals with schizophrenia as well as among non-schizophrenic cocaine abusers. Cognitive deficits in these areas, moreover, have been associated w
Autor:
James C.-Y. Chou
Publikováno v:
CNS Spectrums. 14:6-8
Mixed episode is one of the more difficult-to-treat conditions in bipolar disorder. The presence of mixed features (symptoms of both depression and mania in a single acute episode) is associated with both poorer acute treatment response and poorer lo